← Leaderboards
Eli Boritz
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusIn VivoVirus ReplicationLaboratoriesTissue SampleImmunologicsCell TypeCellsSamplingImmune ResponseEmulsionsSingle MoleculeSequence AnalysisGenetic VariationEvolutionMutationDetectionAntiretroviral TherapyCd4 Positive T LymphocytesTranscriptomicsFlow CytometryGene Expression ProfileInstitutionInterruption
Grant awards (25)
HIV persistence in vivo$1,423,455
ZIA · FY2025 · AI · contact PI
High-throughput, single-molecule sequence analysis of virus populations in vivo$745,679
ZIA · FY2025 · AI · contact PI
Spatial Multi-omic Analysis of HIV-infected Cell Reservoirs in the Tumor Microenvironment$740,000
ZIA · FY2025 · AI · contact PI
Persistence and Evolution of SARS-CoV-2$259,259
ZIA · FY2025 · AI · contact PI
HIV persistence in vivo$1,279,134
ZIA · FY2024 · AI · contact PI
High-throughput, single-molecule sequence analysis of virus populations in vivo$633,831
ZIA · FY2024 · AI · contact PI
Persistence and Evolution of SARS-CoV-2$333,830
ZIA · FY2024 · AI · contact PI
High-throughput, single-molecule sequence analysis of virus populations in vivo$1,625,595
ZIA · FY2023 · AI · contact PI
HIV persistence in vivo$1,234,725
ZIA · FY2023 · AI · contact PI
Persistence and Evolution of SARS-CoV-2$278,238
ZIA · FY2023 · AI · contact PI
HIV persistence in vivo$1,368,258
ZIA · FY2022 · AI · contact PI
High-throughput, single-molecule sequence analysis of virus populations in vivo$567,065
ZIA · FY2022 · AI · contact PI
Persistence and Evolution of SARS-CoV-2$104,874
ZIA · FY2022 · AI · contact PI
HIV persistence in vivo$1,325,455
ZIA · FY2021 · AI · contact PI
High-throughput, single-molecule sequence analysis of virus populations in vivo$476,665
ZIA · FY2021 · AI · contact PI
Persistence and Evolution of SARS-CoV-2$63,123
ZIA · FY2021 · AI · contact PI
HIV persistence in vivo$1,403,612
ZIA · FY2020 · AI · contact PI
High-throughput, single-molecule sequence analysis of virus populations in vivo$382,177
ZIA · FY2020 · AI · contact PI
Persistence and Evolution of SARS-CoV-2$250,000
ZIA · FY2020 · AI · contact PI
HIV persistence in vivo$2,419,534
ZIA · FY2019 · AI · contact PI
High-throughput single-cell analysis in microfluidically-generated droplets$127,344
ZIA · FY2019 · AI · contact PI
HIV persistence in vivo$2,196,968
ZIA · FY2018 · AI · contact PI
High-throughput single-cell analysis in microfluidically-generated droplets$84,130
ZIA · FY2018 · AI · contact PI
HIV persistence in vivo$1,885,466
ZIA · FY2017 · AI · contact PI
High-throughput single-cell analysis in microfluidically-generated droplets$569,673
ZIA · FY2017 · AI · contact PI